Avandia® (or rosiglitazone maleate) is a popular prescription drug, manufactured by GlaxoSmithKline, used to treat “type-2” or “adult-onset” diabetes. Recently, due to concerns over serious side effects, the U.S. Food and Drug Administration (FDA) announced that Avandia® would carry a “black box” warning.
According to the FDA safety alert, clinical trials have shown that with Avandia® “there is a potentially significant increase in the risk of heart attack and heart-related.”
While doubts as to Avandia®’s safety have persisted, the drug is nonetheless used by more 2 million people. Approved for diabetes treatment in 1999, an estimated 60+ million prescriptions for Avandia® have been written. If you or a loved one has taken Avandia® and has experienced an adverse reaction, contact Frank M. Eidson, P.A., today and schedule a free consultation.
Designed to increase the body’s sensitivity to insulin and used to treat type-2, non-insulin dependent diabetes – a serious, life-threatening disease that affects about 18 to 20 million Americans – Avandia® has been on the market since 1999. Left untreated, type 2 diabetes may result in kidney disease, heart disease, stroke, blindness, neuropathy, and a host of other complications.
When Avandia® hit the market it did so with a high degree of promise and initially the reports of its effectiveness were positive. However, reports soon surfaced linking Avandia® to serious side effects. In fact, one study concluded that individuals taking Avandia® were 43 percent more likely to have a heart attack. Other reports have disagreed with these findings, and the controversy has not been resolved.
Since its release, the FDA has been monitoring Avandia®’s link to several heart-related adverse events (including fluid retention, edema and congestive heart failure). The FDA has updated the product’s labeling on several. This latest update included a new warning about a potential increase in heart attacks and heart-related chest pain in some individuals using Avandia®.
The FDA is advising patients who are taking Avandia® - especially those who are known to have underlying heart disease or who are at high risk of heart attack – to talk to their doctor about this new information as they evaluate the available treatment options for their type 2 diabetes. Due to the seriousness of type 2 diabetes, Avandia® patients should not discontinue their medication unless specifically directed by their physicians.
Our courtroom-seasoned personal injury attorneys are currently evaluating Avandia® claims. Contact Frank M. Eidson, P.A., today for a free consultation.
At the Orlando law office of Frank M. Eidson, P.A., our experienced personal injury attorneys boast a wealth of courtroom experience. We have handled numerous claims involving dangerous or defective drugs. Currently, we are investigating claims involving the type 2 diabetes drug Avandia®.
Our legal team will represent you intelligently and aggressively. To discuss your potential claim with an attorney at our Florida law office, contact the Frank M. Eidson, P.A., today.
To speak with one of our courtroom-seasoned personal injury attorneys, contact the Orlando law office of Frank M. Eidson, P.A., today and schedule a free consultation. We are presently investigating claims involving Avandia®.
In some studies, Avandia® has been linked to serious side effects. If you have been diagnosed with Avandia® side effects, our personal injury lawyers may be able to help. Contact Avandia-Lawyer.tv for a free consultation. Please bring any of the following information:
Please note: Talk to your doctor before taking any action. Do not discontinue your medication unless specifically directed by your physician. According to the FDA, “there is inherent risk associated with switching patients with diabetes from one treatment to another…”